Tissue factor and its measurement in whole blood, plasma, and microparticles

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 8, 2010, Pages 865-875

  Key, Nigel S ^a   MacKman, Nigel ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Microparticle; plasma; thrombosis; tissue factor; whole blood

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; THROMBOPLASTIN ANTIGEN; UNCLASSIFIED DRUG;

BLOOD; FLOW CYTOMETRY; HUMAN; NONHUMAN; PLASMA; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; THROMBOSIS; VALIDATION STUDY;

ANIMALS; BLOOD PROTEINS; CELL-DERIVED MICROPARTICLES; CHEMISTRY TECHNIQUES, ANALYTICAL; HUMANS; PLASMA; THROMBOPLASTIN; THROMBOSIS;

EID: 78149310003     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1267040     Document Type: Review

References (99)

1. Boulton F. A hundred years of cascading started by Paul Morawitz (18791936), a pioneer of haemostasis and of transfusion. Transfus Med 2006 16 (1) 1-10
2. Nemerson Y. Tissue factor and hemostasis. Blood 1988 71 (1) 1-8
3. Mackman N, Tilley R E., Key N S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007 27 (8) 1687-1693
4. ?sterud B, Bj?rklid E. Sources of tissue factor. Semin Thromb Hemost 2006 32 (1) 11-23
5. Drake T A., Morrissey J H., Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989 134 (5) 1087-1097
6. Giesen P L., Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999 96 (5) 2311-2315
7. Butenas S, Mann K G. Active tissue factor in blood? Nat Med 2004 10 (11) 1155-1156, correspondence
8. Bogdanov V Y., Hartcock J, Nemerson Y. Active tissue factor in blood? Nat Med 2004 10 (11) 1155-1156; author reply 1156
9. Egorina E M., Sovershaev M A., Bj?rk?y G et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 2005 25 (7) 1493-1498
10. Johnson G J., Leis L A., Bach R R. Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty. Thromb Haemost 2009 102 (4) 728-734
11. Morel O, Toti F, Hugel B et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006 26 (12) 2594-2604
12. Diamant M, Tushuizen M E., Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004 34 (6) 392-401
13. Zillmann A, Luther T, M?ller I et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001 281 (2) 603-609
14. Vandendries E R., Furie B C., Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004 92 (3) 459-466 (Pubitemid 39248002)
15. Polgar J, Matuskova J, Wagner D D. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005 3 (8) 1590-1596
16. Bauer K A., Kass B L., ten Cate H, Hawiger J J., Rosenberg R D. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990 76 (4) 731-736
17. ?sterud B, Rapaport S I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977 74 (12) 5260-5264
18. Bauer K A., Mannucci P M., Gringeri A et al. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood 1992 79 (8) 2039-2047
19. ten Cate H, Bauer K A., Levi M et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993 92 (3) 1207-1212
20. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 2009 108 (5) 1447-1452
21. Bach R R. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006 26 (3) 456-461
22. Bach R R., Moldow C F. Mechanism of tissue factor activation on HL-60 cells. Blood 1997 89 (9) 3270-3276
23. Chen V M., Ahamed J, Versteeg H H., Berndt M C., Ruf W, Hogg P J. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006 45 (39) 12020-12028
24. Ahamed J, Versteeg H H., Kerver M et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A 2006 103 (38) 13932-13937
25. Reinhardt C, von Br?hl M L., Manukyan D et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008 118 (3) 1110-1122
26. Cho J, Furie B C., Coughlin S R., Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008 118 (3) 1123-1131
27. Bach R R., Monroe D. What is wrong with the allosteric disulfide bond hypothesis? Arterioscler Thromb Vasc Biol 2009 29 (12) 1997-1998
28. Pendurthi U R., Ghosh S, Mandal S K., Rao L V. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 2007 110 (12) 3900-3908
29. Kothari H, Sen P, Pendurthi U R., Rao L V. Bovine protein disulfide isomerase-enhanced tissue factor coagulant function: is phospholipid contaminant in it the real culprit? Blood 2008 111 (6) 3295-3296
30. Broze G J. Jr. Tissue factor pathway inhibitor. Thromb Haemost 1995 74 (1) 90-93
31. Santucci R A., Erlich J H., Labriola J et al. Measurement of tissue factor activity in whole blood. Thromb Haemost 2000 83 (3) 445-454
32. Marsik C, Quehenberger P, Mackman N, ?sterud B, Luther T, Jilma B. Validation of a novel tissue factor assay in experimental human endotoxemia. Thromb Res 2003 111 (45) 311-315
33. Gregory S A., Edgington T S. Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. J Clin Invest 1985 76 (6) 2440-2445
34. Rivers R P., Hathaway W E., Weston W L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975 30 (3) 311-316
35. ?sterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983 49 (1) 5-7
36. Nieuwland R, Berckmans R J., McGregor S et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000 95 (3) 930-935
37. Key N S., Slungaard A, Dandelet L et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998 91 (11) 4216-4223
38. Aras O, Shet A, Bach R R. et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004 103 (12) 4545-4553
39. Boden G, Vaidyula V R., Homko C, Cheung P, Rao A K. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose. J Clin Endocrinol Metab 2007 92 (11) 4352-4358
40. Boden G, Rao A K. Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation. Curr Diab Rep 2007 7 (3) 223-227
41. Rao A K., Vaidyula V R., Bagga S et al. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease. Thromb Haemost 2006 96 (6) 738-743
42. Tutar E, Ozcan M, Kilickap M et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 2003 108 (13) 1581-1584
43. Vaidyula V R., Criner G J., Grabianowski C, Rao A K. Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res 2009 124 (3) 259-261
44. Misumi K, Ogawa H, Yasue H et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 1998 81 (1) 22-26
45. Parhami-Seren B, Butenas S, Krudysz-Amblo J, Mann K G. Immunologic quantitation of tissue factors. J Thromb Haemost 2006 4 (8) 1747-1755
46. Albrecht S, Kotzsch M, Siegert G et al. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 1996 75 (5) 772-777
47. Khorana A A., Francis C W., Menzies K E. et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008 6 (11) 1983-1985
48. Censarek P, Bobbe A, Grandoch M, Schr?r K, Weber A A. Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb Haemost 2007 97 (1) 11-14
49. Sommeijer D W., Hansen H R., van Oerle R et al. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with type 2 diabetes. J Thromb Haemost 2006 4 (3) 574-580
50. Zumbach M, Hofmann M, Borcea V et al. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes 1997 105 (4) 206-212
51. Del Conde I, Bharwani L D., Dietzen D J., Pendurthi U, Thiagarajan P, L?pez J A. Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 2007 5 (1) 70-74
52. Yu J L., May L, Lhotak V et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005 105 (4) 1734-1741
53. Bom V J., Bertina R M. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J 1990 265 (2) 327-336
54. Telgt D S., Macik B G., McCord D M., Monroe D M., Roberts H R. Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor. Thromb Res 1989 56 (5) 603-609
55. Bogdanov V Y., Cimmino G, Tardos J G., Tunstead J R., Badimon J J. Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost 2009 7 (5) 894-897
56. Van Dreden P, Rousseau A, Savoure A, Lenormand B, Fontaine S, Vasse M. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction. Blood Coagul Fibrinolysis 2009 20 (8) 635-641
57. Butenas S, Undas A, Gissel M T., Szuldrzynski K, Zmudka K, Mann K G. Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 2008 99 (1) 142-149
58. Sambola A, Osende J, Hathcock J et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003 107 (7) 973-977 (Pubitemid 36258719)
59. Ollivier V, Wang J, Manly D et al. Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res 2010 125 (1) 90-96
60. Haubold K, Rink M, Spath B et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 2009 101 (6) 1147-1155
61. Dvorak H F., Van DeWater L, Bitzer A M. et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983 43 (9) 4434-4442
62. Satta N, Toti F, Feugeas O et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994 153 (7) 3245-3255
63. Himber J, Wohlgensinger C, Roux S et al. Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost 2003 1 (5) 889-895
64. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C., Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004 104 (10) 3190-3197
65. Hathcock J J., Nemerson Y. Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood 2004 104 (1) 123-127
66. Hoffman M, Whinna H C., Monroe D M. Circulating tissue factor accumulates in thrombi, but not in hemostatic plugs. J Thromb Haemost 2006 4 (9) 2092-2093
67. Hrachovinov? I, Cambien B, Hafezi-Moghadam A et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003 9 (8) 1020-1025
68. Day S M., Reeve J L., Pedersen B et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005 105 (1) 192-198
69. Wang L, Miller C, Swarthout R F., Rao M, Mackman N, Taubman M B. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood 2009 113 (3) 705-713
70. Kretz C A., Vaezzadeh N, Gross P L. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 2010 30 (5) 900-908
71. Bir? E, Sturk-Maquelin K N., Vogel G M. et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003 1 (12) 2561-2568
72. Davila M, Amirkhosravi A, Coll E et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 2008 6 (9) 1517-1524
73. Thomas G M., Panicot-Dubois L, Lacroix R, Dignat-George F, Lombardo D, Dubois C. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 2009 206 (9) 1913-1927
74. Diamant M, Nieuwland R, Pablo R F., Sturk A, Smit J W., Radder J K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002 106 (19) 2442-2447
75. Hron G, Kollars M, Weber H et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007 97 (1) 119-123
76. Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb Res 2008 122 (Suppl 1) S47-S54
77. Jy W, Horstman L L., Jimenez J J. et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004 2 (10) 1842-1851
78. Mobarrez F, Antovic J, Egberg N et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010 125 (3) e110-e116
79. Jy W, Horstman L L., Jimenez J J. et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004 2 1842-1851
80. Mallat Z, Benamer H, Hugel B et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 101 (8) 841-843
81. Shet A S., Aras O, Gupta K et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003 102 (7) 2678-2683
82. Lacroix R, Robert S, Poncelet P, Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010 36 (8) 807-818
83. Zwaal R F., Schroit A J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997 89 (4) 1121-1132
84. Perez-Pujol S, Marker P H., Key N S. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A 2007 71 (1) 38-45
85. Amabile N, Gu?rin A P., Leroyer A et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005 16 (11) 3381-3388
86. Nieuwland R. Cellular origin of microparticles exposing tissue factor in cancer: a mixed double? J Thromb Haemost 2008 6 (9) 1514-1516
87. Del Conde I, Shrimpton C N., Thiagarajan P, L?pez J A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005 106 (5) 1604-1611
88. Zwicker J I., Liebman H A., Neuberg D et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009 15 (22) 6830-6840
89. Lawrie A S., Harrison P, Cardigan R A., Mackie I J. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008 95 (3) 197-204
90. Gabriel D A., Giodano K. Microparticle sizing and counting using light scattering methods. Semin Thromb Hemost 2010 36 (8) 824-832
91. Berckmans R J., Neiuwland R, B?ing A N., Romijn F P., Hack C E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001 85 (4) 639-646
92. Aupeix K, Hugel B, Martin T et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997 99 (7) 1546-1554
93. Kushak R I., Nestoridi E, Lambert J, Selig M K., Ingelfinger J R., Grabowski E F. Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res 2005 116 (5) 409-419
94. Bajaj M S., Ghosh M, Bajaj S P. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications. J Thromb Haemost 2007 5 (7) 1493-1499
95. Tesselaar M E., Romijn F P., Van Der Linden I K., Prins F A., Bertina R M., Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007 5 (3) 520-527
96. Bakouboula B, Morel O, Faure A et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008 177 (5) 536-543
97. Tilley R E., Holscher T, Belani R, Nieva J, Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 2008 122 (5) 604-609
98. Manly D A., Wang J, Glover S L. et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 2010 125 (6) 511-512
99. Wang J G., Manly D, Kirchhofer D, Pawlinski R, Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost 2009 7 (7) 1092-1098